117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study

Andreas Pircher, Szabolcs Soter, Michael A. W. Eaton, G. Galffy, D. Kowalski, Atsushi Hata, Abdhiel Bustamante-Navarrete, Nikolaj Frost, E. Levchenko, Mariana P. Monteiro, Anoop Haridass, M. Bouchard, M.V. Bluthgen, M-J. Ahn, B.G.M. Hughes, Amy C. Durham, Yiquan Xu, Ayman Samkari, A. Song, Salma K. Jabbour